Michael Elowitz

Michael Elowitz is the Roscoe Gilkey Dickinson Professor of Biology and Bioengineering at the California Institute of Technology (Caltech) and an Investigator at the Howard Hughes Medical Institute (HHMI). He leads the Elowitz Lab, which focuses on synthetic and systems biology, designing biological circuits to uncover principles of gene regulation and develop therapeutic tools. His work spans protein circuit engineering, cell signaling, and developmental biology, with applications in cell therapies and lineage tracking.

Education:

• B.A., University of California, 1992
• M.A. and Ph.D., Princeton University, 1999

Research Interests: Elowitz's lab pioneers synthetic biology approaches to create programmable genetic circuits, study noise in gene expression, and model developmental processes. Key areas include:

• Design of synthetic gene circuits for cell fate control
• Mechanisms of cell signaling and decision-making
• MEMOIR (Molecularly Encoded Memory In REporting) systems for lineage tracking
• Engineering programmable cell death pathways

Key Contributions: Notable achievements include the first synthetic genetic oscillator (Repressilator), foundational work on noise in gene expression, and development of lineage recording tools. His research bridges fundamental science and translational applications, including therapies for genetic disorders like Rett syndrome.

Awards & Recognition:

• HHMI Investigator (2008–present)
• AAAS Fellow (2015)
• Presidential Early Career Award for Scientists and Engineers (2005)

Labs/Teams: The Elowitz Lab collaborates across disciplines, combining experimental and computational approaches. Key projects include synthetic embryo models, programmable cell death circuits, and MEMOIR-based lineage tracing systems.